Helix BioPharma Corp.

OTCPK:HBPC.F Stock Report

Market Cap: US$31.9m

Helix BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:HBPC.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Aug 23BuyUS$368,781Jerzy WilczewskiIndividual2,777,778US$0.13
21 Aug 23BuyUS$53,104Jerzy LeszczynskiIndividual400,000US$0.13

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of HBPC.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions26,363,17211.5%
Individual Insiders39,219,87517.1%
General Public163,858,03671.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.7%.


Top Shareholders

Top 4 shareholders own 28.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
Jerzy Wilczewski
33,944,931US$4.7m0%no data
11.5%
CAIAC Fund Management AG
26,363,172US$3.7m0%0.83%
1.39%
Jacek Antas
3,191,600US$443.1k0%no data
0.91%
Jerzy Leszczynski
2,083,344US$289.2k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.